{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/65736d39d32e730012c98919/680bb8a32e4e0a1b46c93b1b?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Navigating Biotech’s New Normal, Applying AI to Cas9 Enzymes, and Sequencing Generations","description":"<p>The seismic changes made by the current administration in the United States continue to impact the scientific community. The business news segment of this week’s episode covers the effects of job cuts on biotech, Roche’s manufacturing and R&amp;D plans amid tariff threats, and shares an update on Eli Lilly’s diabetes pill.&nbsp;Also, in honor of DNA Day, we reminisce about how far the field has come since the discovery of the structure of DNA and the completion of the Human Genome Project. We also talk about today’s DNA-related advances that use machine learning to design tailored Cas9 proteins and multiple sequencing technologies to study mutation rates in four generations of the same family. </p><p><br></p><p>Join <em>GEN</em> editors Corinna Singleman, PhD, Alex Philippidis, Fay Lin, PhD, and Uduak Thomas for a discussion of the latest biotech and biopharma news.&nbsp;</p><p><br></p><p>Listed below are links to the <em>GEN</em> stories referenced in this episode of <em>Touching Base:</em></p><p><br></p><p><a href=\"https://www.genengnews.com/topics/drug-discovery/after-job-cuts-were-entering-a-very-new-territory-for-biotech/\" rel=\"noopener noreferrer\" target=\"_blank\">After Job Cuts, “We’re Entering a Very New Territory for Biotech.</a></p><p><a href=\"https://www.genengnews.com/topics/drug-discovery/after-job-cuts-were-entering-a-very-new-territory-for-biotech/\" rel=\"noopener noreferrer\" target=\"_blank\"> </a>By Alex Philippidis, <em>GEN Edge</em>, April 17, 2025&nbsp;</p><p><br></p><p><a href=\"https://www.genengnews.com/topics/bioprocessing/roche-commits-50b-to-u-s-manufacturing-rd-as-tariffs-loom/\" rel=\"noopener noreferrer\" target=\"_blank\">Roche Commits $50B to U.S. Manufacturing, R&amp;D as Tariffs Loom </a></p><p>By Alex Philippidis, <em>GEN Edge</em>, April 22, 2025&nbsp;</p><p><br></p><p><a href=\"https://www.genengnews.com/topics/drug-discovery/stockwatch-investors-hungry-for-lilly-after-diabetes-pill-aces-phase-iii-trial/\" rel=\"noopener noreferrer\" target=\"_blank\">StockWatch: Investors Hungry for Lilly after Diabetes Pill Aces Phase III Trial </a></p><p>By Alex Philippidis, <em>GEN Edge</em>, April 20, 2025</p><p>&nbsp;</p><p><a href=\"https://www.genengnews.com/topics/genome-editing/machine-learning-engineers-bespoke-cas9-enzymes-for-gene-editing/\" rel=\"noopener noreferrer\" target=\"_blank\">Machine Learning Engineers Bespoke Cas9 Enzymes for Gene Editing</a></p><p>By Fay Lin, PhD, <em>GEN</em>, April 22, 2025</p><p><br></p><p><a href=\"https://www.genengnews.com/topics/omics/multi-platform-sequencing-study-of-four-generations-sheds-light-on-mutation-rates/\" rel=\"noopener noreferrer\" target=\"_blank\">Multi-Platform Sequencing Study of Four Generations Sheds Light on Mutation Rates</a></p><p><em>GEN</em>, April 23, 2025&nbsp;</p>","author_name":"Genetic Engineering & Biotechnology News (GEN)"}